Wednesday, August 23, 2017 9:27:00 PM
I'm going to speak to my lawyer about filing a class action lawsuit. They blatantly deceived investors, myself included, by stating that the reason for the RS was to uplist to Nasdaq when they knew fully well that they did not meet the requirements. If this was any company listed on a major exchange they would be sued out the ass. SEC rules apply to all publicly traded companies including scams like this one.
Recent GTBP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 11:05:14 AM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/06/2026 09:01:09 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/06/2026 09:01:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 12:05:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2026 05:15:19 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/30/2026 10:12:20 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/21/2026 09:15:32 PM
- 5 Assets Securing the 2026 Material Cycle • GlobeNewswire Inc. • 01/16/2026 04:18:58 PM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (US) • 01/16/2026 01:00:00 PM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (Canada) • 01/16/2026 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/08/2026 09:19:06 PM
- Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
- Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines • PR Newswire (US) • 12/19/2025 12:55:00 PM
- Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines • PR Newswire (Canada) • 12/19/2025 12:55:00 PM
- Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 • PR Newswire (Canada) • 12/19/2025 12:44:00 PM
- Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 • PR Newswire (US) • 12/19/2025 12:44:00 PM
- 5 Companies Solving the Invisible Crisis • GlobeNewswire Inc. • 12/15/2025 03:54:35 PM
- Platform Technologies Drive $211B Surge in Precision Cancer Treatment • PR Newswire (US) • 12/11/2025 03:17:00 PM
- Platform Technologies Drive $211B Surge in Precision Cancer Treatment • PR Newswire (Canada) • 12/11/2025 03:17:00 PM
- 5 Assets Delivering Proof in a Speculative Market • GlobeNewswire Inc. • 12/11/2025 02:14:48 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (US) • 12/04/2025 05:20:00 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (Canada) • 12/04/2025 05:20:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:24:28 PM
